Oncology

  1. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
    €8,382.72
  2. Vitrakvi (larotrectinib)
    Vitrakvi (larotrectinib)
    by Bayer
    for Solid Tumor
    €15,204.00
  3. Vizimpro (dacomitinib)
    Vizimpro (dacomitinib)
    by Pfizer Limited
    for Lung Cancer
    €18,420.00
  4. Copiktra (duvelisib)
    Copiktra (duvelisib)
    by Verastem Inc.
    for Leukemia, Lymphoma
    €18,060.00
  5. Erleada (apalutamide)
    Erleada (apalutamide)
    by Janssen Biotech
    for Prostate Cancer
    €4,225.86
  6. Nerlynx (neratinib)
    Nerlynx (neratinib)
    by Puma biotechnology
    for Breast Cancer
    €18,900.00
  7. Truxima (rituximab)
    Truxima (rituximab)
    by Teva Pharmaceuticals, Celltrion Healthcare Hungary Kft
    for Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis , Polyangiitis
    €852.00
  8. Aliqopa (copanlisib)
    Aliqopa (copanlisib)
    by Bayer
    for Lymphoma
    €7,915.32
  9. Verzenio/Verzenios (abemaciclib)
    Verzenio/Verzenios (abemaciclib)
    by Lilly
    for Breast Cancer
    €1,732.80
View as Grid List

Items 1-9 of 38

Page
per page
Set Descending Direction